Valuation: Boston Scientific Corporation

Market Cap 60.84B 54.49B 50.12B 45.41B 84.89B 5,777B 86.48B 598B 240B 3,039B 228B 223B 9,583B P/E 2026 *
16.9x
P/E 2027 * 18.2x
Enterprise Value 72.68B 65.09B 59.88B 54.25B 101B 6,901B 103B 714B 287B 3,630B 273B 267B 11,448B EV / Sales 2026 *
3.47x
EV / Sales 2027 * 3.26x
Free-Float
82.47%
Yield 2026 *
-
Yield 2027 * -
1 day-1.66%
1 week-8.12%
Current month-3.83%
1 month-3.83%
3 months-8.74%
6 months-27.13%
Current year-55.97%
1 week 39.57
Extreme 39.57
46.07
1 month 39.57
Extreme 39.57
46.16
Current year 39.57
Extreme 39.57
100.9
1 year 39.57
Extreme 39.57
105.65
3 years 39.57
Extreme 39.57
109.5
5 years 34.98
Extreme 34.98
109.5
10 years 19.67
Extreme 19.67
109.5
Manager TitleAgeSince
Chief Executive Officer 61 01/11/2011
Director of Finance/CFO 52 30/06/2025
Chief Tech/Sci/R&D Officer - 01/09/2009
Director TitleAgeSince
Chairman 61 03/05/2016
Director/Board Member 74 01/03/2014
Director/Board Member 74 15/04/2016
Date Insider Type Main position Quantity % Market Cap. Importance
25/8/26 Buy

Director

2,040 0.0001%
11/8/26 Other

Controller/Auditor

2,930 0.0002%
10/8/26 Other

Chief Financial Officer

9,908 0.0007%
Change 5-day change 1-year change 3-year change Capi.($)
-1.66%-8.12%-58.26%-16.12% 61.87B
-1.72%+3.44%+25.31%+60.56% 262B
-2.00%+0.75%+7.99%+25.46% 167B
-3.73%-4.48%-18.49%+67.13% 156B
-2.57%+3.30%+10.22%+47.55% 54.44B
0.00%+2.71%-13.09%-6.48% 53.3B
-3.47%+1.04%+21.98%+72.85% 51.07B
+0.84%-3.12%+9.80%+64.47% 50.25B
-3.61%+1.99%+34.94%+95.49% 47.17B
-18.64%-12.41%+138.35%+118.77% 43.8B
Average -3.66%+2.28%+15.87%+52.97% 94.64B
Weighted average by Cap. -2.88%+2.68%+11.27%+51.22%

Financials

2026 *2027 *
Net sales 20.96B 18.78B 17.27B 15.65B 29.25B 1,991B 29.8B 206B 82.68B 1,047B 78.68B 77.01B 3,302B 21.03B 18.83B 17.32B 15.7B 29.34B 1,996B 29.89B 207B 82.92B 1,050B 78.91B 77.23B 3,312B
Net income 3.6B 3.23B 2.97B 2.69B 5.03B 342B 5.12B 35.39B 14.21B 180B 13.52B 13.23B 567B 3.41B 3.06B 2.81B 2.55B 4.76B 324B 4.85B 33.52B 13.46B 170B 12.8B 12.53B 537B
Net Debt 11.84B 10.61B 9.76B 8.84B 16.52B 1,124B 16.83B 116B 46.7B 591B 44.44B 43.5B 1,865B 7.67B 6.87B 6.32B 5.72B 10.7B 728B 10.9B 75.33B 30.24B 383B 28.78B 28.17B 1,208B
Projected Income Statement - Annual - Boston Scientific Corporation
Logo Boston Scientific Corporation
Boston Scientific Corporation specializes in the design, manufacturing and marketing of medical equipment and materials. Net sales break down by area of application as follows: - cardiovascular (66%): products used in cardiology surgeries (35% of net sales), electrophysiology tests (25.1%) cardiac rhythm management (17.6%), peripheral surgeries (7.5%), and other (14.8%); - endodontic surgery (28%): equipment used in endoscopy (51.8% of net sales), and urology (48.2%) ; - neuromodulation (6%). Net sales are distributed geographically as follows: the United States (64.1%), Europe/Middle East/Africa (17.2%), Asia/Pacific (15.4%) and other (3.3%).
Employees
59,000
Date Price Change Volume
30/10/26 USD 41.98 -1.66% 22,466,168
29/10/26 USD 42.69 +0.61% 31,755,378
28/10/26 USD 42.43 -5.84% 69,837,060
27/10/26 USD 45.06 -1.14% 15,139,721
26/10/26 USD 45.58 -0.24% 11,928,715
Trader
Investor
Global
Quality
ESG MSCI
BBB
MarketScreener Ratings - Boston Scientific Corporation
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
31
Last Close Price
41.98USD
Average target price
51.53USD
Spread / Average Target
+22.74%

Quarterly revenue - Rate of surprise

Rate of surprise - Net sales - Quarterly - Boston Scientific Corporation